Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

The First Korean Patient With Severe Aortic Stenosis and Bilateral Iliofemoral Artery Disease Treated With Transcatheter Aortic Valve Implantation by Transsubclavian Approach

  • Lee, Seung-Jun (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Ko, Young-Guk (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Shim, Ji-Young (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Lee, Sak (Department of Thoracic and Cardiovascular Surgery, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Chang, Byung-Chul (Department of Thoracic and Cardiovascular Surgery, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Shim, Jae-Kwang (Department of Anesthesiology and Pain Medicine, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Kwak, Young-Ran (Department of Anesthesiology and Pain Medicine, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Hong, Myeong-Ki (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System)
  • Published : 2012.11.30
⟨ Previous Next ⟩

Abstract

Transcatheter aortic valve implantation (TAVI) is indicated as an alternative treatment modality to surgical aortic valve replacement for high risk patients. The standard retrograde approach through the femoral artery is not feasible in the case of unfavorable iliofemoral anatomy or severe peripheral arterial disease (PAD). However, patients with aortic stenosis (AS) have a higher prevalence of for PAD because both diseases are consequences of atherosclerotic degenerative changes. Transsubclavian, transapical, and direct access to the ascending aorta by thoracotomy are alternative routes for the TAVI procedure. In this report, we present the first Korean patient with symptomatic severe AS and bilateral iliofemoral artery disease who was successfully treated with TAVI using a CoreValve (Medtronic, Minneapolis, MN, USA) by transsubclavian approach.

Keywords

References

  1. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005;26:2714-20. https://doi.org/10.1093/eurheartj/ehi471
  2. Aronow WS, Ahn C, Kronzon I. Association of valvular aortic stenosis with symptomatic peripheral arterial disease in older persons. Am J Cardiol 2001;88:1046-7. https://doi.org/10.1016/S0002-9149(01)01990-7
  3. Bruschi G, De Marco F, Fratto P, et al. Direct aortic access through right minithoracotomy for implantation of self-expanding aortic bioprosthetic valves. J Thorac Cardiovasc Surg 2010;140:715-7. https://doi.org/10.1016/j.jtcvs.2010.02.030
  4. Da Gama Ribeiro V, Vouga L, Markowitz A, et al. Vascular access in transcatheter aortic valve implantation. Int J Cardiovasc Imaging 2011; 27:1235-43. https://doi.org/10.1007/s10554-011-9900-8
  5. Bosmans JM, Kefer J, De Bruyne B, et al. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian National Registry. Interact Cardiovasc Thorac Surg 2011;12:762-7. https://doi.org/10.1510/icvts.2010.253773
  6. Witkowski A, Dabrowski M, Chmielak Z, et al. Transcatheter aortic valve implantation using transfemoral/transsubclavian or transapical approach: 30-day follow-up of the initial 30 patients. Kardiol Pol 2011;69:105-14.
  7. Petronio AS, De Carlo M, Bedogni F, et al. Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv 2010;3:359-66. https://doi.org/10.1161/CIRCINTERVENTIONS.109.930453
  8. Moynagh AM, Scott DJ, Baumbach A, et al. CoreValve transcatheter aortic valve implantation via the subclavian artery: comparison with the transfemoral approach. J Am Coll Cardiol 2011;57:634-5. https://doi.org/10.1016/j.jacc.2010.08.642
  9. Fraccaro C, Napodano M, Tarantini G, et al. Expanding the eligibility for transcatheter aortic valve implantation the trans-subclavian retrograde approach using: the III generation CoreValve revalving system. JACC Cardiovasc Interv 2009;2:828-33. https://doi.org/10.1016/j.jcin.2009.06.016